GL1X · GenesisL1 explorer

MolNFT v1 · #57864 · protein

Crystal structure of human TYW5

3AL5 · Jmjc domain-containing protein C2ORF60: “Crystal structure of human TYW5”. X-ray diffraction, 1 ligand (MG), 15 pockets (best druggability 0.71). MolNFT v1 #57864 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3AL5
Type
protein
Length
1,205 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Jmjc domain-containing protein C2ORF60
UniProt
A2RUC4
Ligands
MG
Pockets
15 · best druggability 0.71

Structure

x-ray diffraction · 4 distinct chains · 30% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AJmjc domain-containing protein C2ORF60protein30230% helix, 25% strandA2RUC4
BJmjc domain-containing protein C2ORF60protein31131% helix, 26% strandA2RUC4
CJmjc domain-containing protein C2ORF60protein28429% helix, 25% strandA2RUC4
DJmjc domain-containing protein C2ORF60protein30830% helix, 28% strandA2RUC4

Ligands and binding sites

  • MG · Magnesium ion · metal · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14290.710.8250empty
23190.680.8354empty
32400.670.8440MG
42480.630.8240empty
5860.610.8817empty

Interfaces

2 interfaces between chains.

  • C–D · 2545 Ų buried · 19 hydrogen bonds · protein-protein
  • A–B · 2463 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 3AL5 · Crystal structure of Human TYW5 · the same entry in another collection · chain D against D, TM-score 1.00
  • A2RUC4 · AlphaFold monomer V2.0 prediction for tRNA wybutosine-synthesizing protein 5 (A2RUC4) · a predicted model of the same protein · chain D against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.